Fusion Antibodies: results underwhelm
Fusion Antibodies (LON: FAB), specialists in pre-clinical antibody discovery, for both therapeutic drug and diagnostic applications, underwhelmed with its interim results for the six months ending 30 September 2020, at least for a business with its high rating – the current market capitalisation is £29m.
Revenues rose 8.5% of £1.90m with losses remaining stable at £0.47m.
They expanded their R&D programme in the period by 50% to £271k to include a COVID-19 target…
Sign up and read the full article
Register to continue reading our content.
Get FREE access now
Already a member? Login
Previous article
Next article
More on Advanced Medical Solutions
16/03/2024 · Podcasts
This episode discusses Bitcoin's surging price, the UK competition authority's probe into the veterinary sector, Trainline's growth and…
13/03/2024 · Company Insights
We pick through the latest results from two of AIM’s world leaders. The shares of both…
More on Argentex Group PLC
03/02/2024 · Podcasts
In this episode of the Investor’s Champion Podcast, Chris and Lee run through key news from…
30/01/2024 · Company Insights
Even in the most challenging of markets this business still generated significant profits and continued to pay…
More on Frasers Group
05/01/2024 · Portfolio
Our portfolio company covered here dominates the market for athletic footwear, but is it the best…
28/06/2023 · Company Insights
Having experienced a dramatic rise and fall over the past decade, Mulberry faces an uncertain future.…
More on Fusion Antibodies PLC
20/11/2020 · Company Insights
Mike Ashley’s Frasers has upped its stake in Mulberry and is obliged to contemplate a full…
28/04/2020 · Company Insights
Announcements included an update from from Burford Capital, which saw its shares bounce strongly, but we still…
More Company Insights
An AIM company hits the jackpot
24/04/2024
This star performer on AIM has an exciting future
Update from a provider of identity software lifts the shares
More on Advanced Medical Solutions
More on Argentex Group PLC
More on Frasers Group
More on Fusion Antibodies PLC
More Company Insights